Is 50 cent the price of the optimal copayment? - a qualitative study of patient opinions and attitudes in response to a 50 cent charge on prescription drugs in a publicly funded health system in Ireland

Abstract

BackgroundA 50 cent prescription levy was introduced in 2010 on the General Medical Services (GMS) scheme (Irish public health insurance). This study sought to examine patient attitudes and opinions surrounding the 50 cent copayment. Given the small momentary value of the prescription fee, these results are of interest to policymakers internationally who wish to reduce copayments rather than abolish them.MethodsA qualitative research design was used; semi structured interviews were carried out. Twenty four GMS eligible participants were interviewed in 23 interviews. Fifteen females and 9 males took part. Ages varied from 31- >70 years. Patients were invited to be interviewed in both independent and chain community pharmacies in three types of setting; 1) a socially deprived urban area, 2) a suburban affluent area and 3) a rural area. The Framework method was used for data management and analysis using QSR International’s NVivo 9.2 qualitative data analysis software. The “Francis method” was used to test for data saturation.ResultsResults are of interest to the Irish context and also at a broader international level. Patients were mostly accepting of the prescription levy with some reservations concerning an increased price and the way in which generated revenue would be used by government. Participants identified waste of prescription drugs at the hand of patients (moral hazard), but there was discordant opinion on whether the 50 cent copayment would halt this moral hazard. Interviewees felt the levy was affordable, albeit some may suffer a financial impact more than others.ConclusionsThis qualitative study gives important insights into the experiences of GMS patients with regard to the prescription levy. Information regarding the appropriateness of a 50 cent copayment as a symbolic copayment needs to be confirmed by quantitative analysis. Further insight is required from a younger population.

A systematic review of strategies used for controlling consumer moral hazard in health systems

“…The majority of the outcomes analyzed included demand and utilization of health services [ 5 , 15 , 18 – 24 , 30 , 33 , 37 – 40 , 43 – 45 , 47 – 51 , 55 , 56 , 58 , 60 , 62 – 65 , 68 – 71 , 75 , 84 , 86 ] and health services costs and expenditures, optimality and efficiency of strategies [ 5 , 15 , 30 – 32 , 36 , 37 , 39 , 41 – 44 , 53 , 54 , 57 , 59 , 68 , 70 , 73 – 76 , 83 , 85 , 87 , 94 ]. Limited studies have addressed other important aspects such as access to low-income people [ 49 , 60 , 68 ], reduction in the consumption of both essential (such as preventive and diagnostic services) and non-essential services [ 24 , 44 , 58 ], and people’s attitudes and acceptance [ 25 , 34 , 52 , 67 ].…”

Adapting simulation responses from judgment-based to analytic-based scores: A process model, case study, and empirical evaluation of managers’ responses among a sample of managers.

“…In Step 4, the researchers met to discuss and revise their initial categories. The research team concluded that saturation (the point at which no new categories emerge from the data; Francis et al, 2010;Sinnott, Guinane, Whelton, & Byrne, 2013) was reached after reviewing the fifth response; they confirmed this by reviewing the remaining 10 sample responses, where no further categories or subcategories emerged. The researchers came to consensus on the final coding scheme (Step 5).…”

Irish GMS Cost Projections and Its Implications between 2016 and 2026

“…Co-payments were introduced as a revenue raising measure. Two Irish studies found both co-payments (€0.50 and €1.50) were associated with larger reductions in adherence to less--essential medicines than essential medicines, with anti-depressant and anxiolytic/hypnotic medicines being the exception [34,35]. In 2013, a number of cost containment measures were introduced.…”